Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Dallas TX, Oklahoma City OK, Houston TX, Fort Smith AR,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
for
Phase 1b, HC-7366, SHARK, Kidney Cancer
Location: Dallas TX, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07401875
Phase 1, Recruiting
Omalizumab Weight-Based Dosing Efficacy Trial
for
Allergies, Food Allergy
Location: Dallas TX, Chapel Hill NC, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 1 - 55
Code: NCT06943534
Phase 2, Recruiting
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
for
Generalized Lipodystrophy
Location: Dallas TX, Ann Arbor MI
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 2+
Code: NCT07220785
Phase 3, Recruiting
Late Onset Alzheimer's Disease
for
Alzheimer Disease
Location: Dallas TX, St Louis MO, Bloomington IN, Indianapolis IN,
Sponsor: Columbia University
Sex: All
Age: 55+
Code: NCT05010603
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
for
Homocystinuria
Location: Dallas TX, Atlanta GA, Chicago IL, Phoenix AZ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 12 - 65
Code: NCT06247085
Phase 3, Recruiting
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
for
Sanfilippo Syndrome Type C
Location: Dallas TX
Sponsor: Phoenix Nest
Sex: All
Age: 1+
Code: NCT05825131
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Dallas TX, Fredericksburg TX, New Braunfels TX,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase 3, Recruiting
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
for
Phenylketonuria
Location: Dallas TX, Aurora CO, Indianapolis IN, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 18 - 65
Code: NCT07477691
Phase 4, Recruiting
Prospective Investigation of Cirrhotic Cardiomyopathy in Humans
for
Cirrhotic Cardiomyopathy
Location: Dallas TX, Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT07658222
Recruiting
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
for
Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
Location: Dallas TX, San Antonio TX, Indianapolis IN,
Sponsor: Hummingbird Bioscience
Sex: All
Age: 18+
Code: NCT06956690
Phase 1, Phase 2, Recruiting
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Dallas TX, Wichita KS, Nashville TN, Iowa City IA,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase 1, Phase 2, Recruiting
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
for
Renal Transplant Failure and Rejection
Location: Dallas TX, Kansas City KS, Metairie LA, Atlanta GA,
Sponsor: ITB-Med LLC
Sex: All
Age: 18 - 70
Code: NCT07508787
Phase 2, Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Dallas TX, Oklahoma City OK, San Antonio TX, Houston TX,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7